Absci
Absci uses generative AI and an integrated drug creation platform to design and optimize biologic drugs, including antibodies, for pharmaceutical companies and patients. Its technology combines AI-driven de novo design, lead optimization, and wet lab validation to create therapeutics against difficult-to-drug targets, aiming to accelerate the development of better biologics for challenging diseases.
Facts
- HQ
- Vancouver, Wash.
- Sectors
- Biotechnology Research
- Founded
- 2011
- Employees
- 159
- Stage
- Public
- Members see funding amounts. .
Is this your organization? Claim it
Founders
-
Sean McClain Founder, CEO & Director
-
Sean McClain CEO and Founder
-
Sean McClain Founder and CEO
-
Sean McClain CEO and Founder
Executives
-
Zach Jonasson Executive, Chief Financial Officer & Chief Business Officer